Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-346925
Filing Date
2012-08-09
Accepted
2012-08-09 14:05:07
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d334262d10q.htm 10-Q 540406
2 EX-31.1 d334262dex311.htm EX-31.1 9738
3 EX-31.2 d334262dex312.htm EX-31.2 9744
4 EX-32.1 d334262dex321.htm EX-32.1 2611
5 EX-32.2 d334262dex322.htm EX-32.2 2591
  Complete submission text file 0001193125-12-346925.txt   6319260

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT opk-20120630.xml EX-101.INS 852766
7 XBRL TAXONOMY EXTENSION SCHEMA opk-20120630.xsd EX-101.SCH 63239
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE opk-20120630_cal.xml EX-101.CAL 78488
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20120630_def.xml EX-101.DEF 251714
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20120630_lab.xml EX-101.LAB 482412
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20120630_pre.xml EX-101.PRE 342327
Mailing Address 4400 BISCAYNE BLVD. SUITE 900 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. SUITE 900 MIAMI FL 33137 305-575-6015
Opko Health, Inc. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 121019762
SIC: 2834 Pharmaceutical Preparations